Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 3Radiation Injuries 1Prostatic Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Hepatitis 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Chemical and Drug Induced Liver Injury 1Brain Injuries 1Bone Cysts 1Anatomic Stage IV Breast Cancer AJCC v8 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Magnetic Resonance Spectroscopy 3Specimen Handling 2Biopsy 2radium Ra 223 dichloride 1pembrolizumab 1binimetinib 1abemaciclib 1X-Rays 1Vorinostat 1Taxes 1Tamoxifen 1Steroids 1Photons 1Paclitaxel 1Letrozole 1Imatinib Mesylate 1Hormones 1Fulvestrant 1Cyclin-Dependent Kinase Inhibitor p18 1Cyclin-Dependent Kinase Inhibitor p16 1Capecitabine 116-fluoroestradiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anatomic Stage IV Breast Cancer AJCC v8 × Steroids × Clear all
NCT07112053 2026-04-06

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

University of Washington

Phase 2 Recruiting
40 enrolled
Breast

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡